Pregnancy Preterm
24
4
6
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 24 trials
100.0%
+13.5% vs benchmark
13%
3 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (24)
The Periviable GOALS Decision Support Tool
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
Engaging Mothers & Babies; Reimagining Antenatal Care for Everyone (EMBRACE) Study
Gestational Diabetes Monitoring and Management
Metformin to Treat Corticosteroids-induced Hyperglycemia
Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age
Oral Health and Adverse Pregnancy Complications
COPE - COVID-19 in Pregnancy and Early Childhood
Evaluation of the Prenatal Trip Assistance Pilot Project
Melatonin Levels in Preterm and Term Newborn Infants
The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat
Laparoscopic Versus Open Appendectomy in Pregnancy
Metformin to Prevent Preterm Birth in Twin Pregnancy
Advanced Multi-Modal Wearable Sensing for the Prediction of Pre-Term Labor
Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study
Progesterone Levels and Pregnancy Results
Materno-fetal Consequences of Symptomatic Dengue in Pregnant Wowen in French Guiana
Evaluating Decisional Regret Among Mothers
Evaluation of Vaginal PAMG-1 Detection by PartoSure Test in Preterm Delivery Threat in Actual Clinical Situation: Randomized Controlled Trial
Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids